Aspen Aerogels (NYSE:ASPN – Get Free Report) updated its third quarter 2026 earnings guidance on Thursday. The company provided earnings per share guidance of -0.110–0.070 for the period, compared to the consensus EPS estimate of -0.130. The company issued revenue guidance of $65.0 million-$80.0 million, compared to the consensus revenue estimate of $56.6 million.
Aspen Aerogels Stock Performance
Shares of NYSE ASPN opened at $6.26 on Friday. The firm’s 50-day moving average price is $5.51 and its 200-day moving average price is $4.42. The company has a quick ratio of 2.54, a current ratio of 2.89 and a debt-to-equity ratio of 0.32. The company has a market cap of $519.22 million, a PE ratio of -4.09 and a beta of 2.99. Aspen Aerogels has a 52-week low of $2.30 and a 52-week high of $9.35.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. The firm had revenue of $49.85 million during the quarter, compared to analysts’ expectations of $42.42 million. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 29.30%. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. As a group, analysts anticipate that Aspen Aerogels will post -0.8 EPS for the current year.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on ASPN
Trending Headlines about Aspen Aerogels
Here are the key news stories impacting Aspen Aerogels this week:
- Positive Sentiment: Aspen reported second-quarter revenue of $49.85 million, exceeding the $42.42 million consensus estimate. Its adjusted loss of $0.22 per share was also slightly better than the expected $0.23 loss. Aspen Aerogels Reports Q2 Loss, Beats Revenue Estimates
- Positive Sentiment: Thermal Barrier revenue reached $29.5 million, an 81% sequential increase, highlighting momentum in Aspen’s electrification-related business. The company also raised its 2026 European Thermal Barrier revenue outlook to $20 million-$30 million. Aspen Aerogels Second-Quarter Results
- Positive Sentiment: Third-quarter revenue guidance of $65 million-$80 million is well above the $56.6 million analyst consensus, while adjusted EBITDA guidance of $7 million-$15 million suggests improving operating leverage. EPS guidance of a $0.07-$0.11 loss is also better than the expected $0.13 loss. Aspen Aerogels Guidance
- Positive Sentiment: Jaguar Land Rover selected Aspen’s PyroThin technology for two next-generation vehicle architectures, adding evidence of potential future automotive demand. Q2 2026 Earnings Presentation
- Neutral Sentiment: Aspen Aerogels’ inclusion in Russell 1000 coverage may improve visibility and potentially attract index-related investor interest, although the direct financial impact is uncertain. Aspen Aerogels Russell 1000 News
- Negative Sentiment: The company remains unprofitable: its second-quarter loss widened from $0.04 per share a year earlier to $0.22, with negative net margin and return on equity. This continuing cash-burn and execution risk may be limiting the market’s reaction to the otherwise favorable results. Aspen Aerogels Q2 Earnings Snapshot
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the company. Hsbc Holdings PLC purchased a new stake in Aspen Aerogels in the 4th quarter worth $66,000. Invesco Ltd. lifted its position in shares of Aspen Aerogels by 237.9% in the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock valued at $11,688,000 after acquiring an additional 2,907,558 shares in the last quarter. XTX Topco Ltd boosted its stake in shares of Aspen Aerogels by 786.1% in the fourth quarter. XTX Topco Ltd now owns 202,030 shares of the construction company’s stock worth $572,000 after acquiring an additional 179,231 shares during the period. Quadrature Capital Ltd boosted its stake in shares of Aspen Aerogels by 248.5% in the fourth quarter. Quadrature Capital Ltd now owns 35,583 shares of the construction company’s stock worth $101,000 after acquiring an additional 25,373 shares during the period. Finally, Numerai GP LLC grew its position in shares of Aspen Aerogels by 1,277.9% during the fourth quarter. Numerai GP LLC now owns 251,888 shares of the construction company’s stock worth $713,000 after purchasing an additional 233,608 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Read More
- Five stocks we like better than Aspen Aerogels
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
- Why These 3 Equal Weight ETFs Have Outperformed the S&P This Year
- MarketBeat Week in Review – 08/03 – 08/07
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
